HIF1A and ovarian cancer: Both miR-125 and miR-199a were shown to inhibit angiogenesis through decreased expression of HIF‐1a (Hypoxia-inducible factor 1-alpha) and VEGF (Vascular Endothelial Growth Factor) in ovarian cancer [24].